Robin Doeswijk

Haag, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

An EHA strategic roadmap for improved care in Europe for AYA patients with malignant and chronic non-malignant hematological diseases.

An EHA strategic roadmap for improved care in Europe for AYA patients with malignant and chronic non-malignant hematological diseases.

Journal: HemaSphere

Published: April 20, 2026

Reduce bureaucracy in clinical trials now.

Reduce bureaucracy in clinical trials now.

Journal: Nature medicine

Published: January 06, 2026

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Journal: Clinical pharmacology and therapeutics

Published: November 08, 2025

A Europe-wide provider perspective of healthcare services for adolescent and young adult patients with haematological conditions: a survey from the Adolescent and Young Adult Taskforce of the European Hematology Association.

A Europe-wide provider perspective of healthcare services for adolescent and young adult patients with haematological conditions: a survey from the Adolescent and Young Adult Taskforce of the European Hematology Association.

Journal: EClinicalMedicine

Published: October 18, 2025

Patient-centered and proportionate safety reporting in clinical trials facilitates evidence-based medicine for the benefit of patients and society: An EHA priority.

Patient-centered and proportionate safety reporting in clinical trials facilitates evidence-based medicine for the benefit of patients and society: An EHA priority.

Journal: HemaSphere

Published: September 09, 2025

Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe.

Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe.

Journal: Cytotherapy

Published: May 30, 2025

The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies.

The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies.

Journal: HemaSphere

Published: April 29, 2025

Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Journal: HemaSphere

Published: March 20, 2025

Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy.

Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy.

Journal: Journal of market access & health policy

Published: September 04, 2024

The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy.

The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy.

Journal: Journal of market access & health policy

Published: January 30, 2024

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care.

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care.

Journal: HemaSphere

Published: February 27, 2023

How a Medical Association Can Make a Difference in a Crisis Situation.

How a Medical Association Can Make a Difference in a Crisis Situation.

Journal: HemaSphere

Published: August 15, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026